Related references
Note: Only part of the references are listed.A pediatric regimen for adolescents and young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trial
Josep-Maria Ribera et al.
CANCER MEDICINE (2020)
Increased survival due to lower toxicity for high-risk T-cell acute lymphoblastic leukemia patients in two consecutive pediatric-inspired PETHEMA trials
Pere Barba et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2019)
A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403
Wendy Stock et al.
BLOOD (2019)
Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemia
N. Toft et al.
LEUKEMIA (2018)
Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia
Nicola Goekbuget et al.
BLOOD (2018)
Acute lymphoblastic leukemia in adolescent and young adults: treat as adults or as children?
Nicolas Boissel et al.
BLOOD (2018)
Rapid identification of BCR/ABL1-like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time-polymerase chain reaction: clinical, prognostic and therapeutic implications
Sabina Chiaretti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Pediatric-Inspired Treatment Regimens for Adolescents and Young Adults With Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia A Review
Stuart E. Siegel et al.
JAMA ONCOLOGY (2018)
Adoption of Pediatric-Inspired Acute Lymphoblastic Leukemia Regimens by Adult Oncologists Treating Adolescents and Young Adults: A Population-Based Study
Lori Muffly et al.
CANCER (2017)
How is the Ph-like signature being incorporated into ALL therapy?
Luke Maese et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2017)
How should we treat the AYA patient with newly diagnosed ALL?
Nicolas Boissel
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2017)
Final results of a single institution experience with a pediatric-based regimen, the augmented Berlin-Frankfurt-Munster, in adolescents and young adults with acute lymphoblastic leukemia, and comparison to the hyper-CVAD regimen
Michael E. Rytting et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
D. Hoelzer et al.
ANNALS OF ONCOLOGY (2016)
Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232
Michael J. Borowitz et al.
BLOOD (2015)
Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia
Nathalie Dhedin et al.
BLOOD (2015)
Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemia
D. J. DeAngelo et al.
LEUKEMIA (2015)
Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study
Valentino Conter et al.
BLOOD (2014)
Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II study by the Japan Adult Leukemia Study Group
F. Hayakawa et al.
BLOOD CANCER JOURNAL (2014)
Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Adults With Philadelphia Chromosome (Ph)-Negative Acute Lymphoblastic Leukemia (ALL): Results From The Group For Research On Adult ALL (GRAALL)
Nathalie Dhedin et al.
BLOOD (2013)
Significant Improvement Of Outcome In Adolescents and Young adults (AYAs) Aged 15-35 Years With Acute Lymphoblastic Leukemia (ALL) With a Pediatric Derived Adult ALL Protocol; Results Of 1529 AYAs In 2 Consecutive Trials Of The German Multicenter Study Group For Adult ALL (GMALL)
Nicola Goekbuget et al.
BLOOD (2013)
Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study
Valentino Conter et al.
BLOOD (2010)
Adolescents and Young Adults with Acute Lymphoblastic Leukemia
Wendy Stock
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2010)
Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the programa espanol de tratamiento en hematologia pediatric-based protocol ALL-96
Josep-Maria Ribera et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
ERK1/2 phosphorylation is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia
Chiara Gregorj et al.
BLOOD (2007)
Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data
V. H. J. van der Velden et al.
LEUKEMIA (2007)
Adult T-cell acute lymphoblastic leukemia:: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol
A Vitale et al.
BLOOD (2006)
NMR1 protein expression is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia
A Tafuri et al.
BLOOD (2002)
Share Paper
